Functional Brands Inc. Receives Nasdaq Delisting Determination – Key Information for Investors
Overview
Functional Brands Inc. (Nasdaq: MEHA), a company specializing in wellness and performance products, has announced that it received a delisting determination notice from The Nasdaq Stock Market LLC. This development is significant and is expected to directly impact shareholders and the company’s stock price.
Key Points from the Announcement
- Nasdaq Delisting Determination: On June 9, 2026, Functional Brands Inc. received a written notification (the “Staff Determination”) from Nasdaq’s Listing Qualifications Department, stating that the company’s common stock will be delisted from The Nasdaq Capital Market.
- Reason for Delisting: The company’s stock had a closing bid price below \$1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). Despite being given 180 calendar days (until June 29, 2026) to regain compliance, the company’s stock price fell further.
- Triggering Event – Low Priced Stocks Rule: Under Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”), the company’s shares had a closing bid price of \$0.10 or less for ten consecutive trading days as of June 8, 2026. This automatically triggered the issuance of a Staff Delisting Determination.
- Immediate Impact: Trading of the company’s common stock is scheduled to be suspended at the opening of business on June 16, 2026. Subsequently, a Form 25-NSE will be filed with the SEC to remove the stock from Nasdaq listing and registration.
What Shareholders Need to Know
- Right to Appeal: The company has the right to request a hearing before the Nasdaq Hearings Panel to appeal the delisting determination. However, the hearing request, accompanied by a non-refundable \$20,000 fee, must be submitted no later than 4:00 p.m. ET on June 16, 2026. Importantly, a timely appeal will not stay the suspension of trading.
- Uncertainty Remains: There is no assurance that the company will be successful in any appeal or that it will be able to regain compliance with Nasdaq’s listing requirements within the timeframe provided by the Panel, if any.
- Potential Share Price Impact: Delisting from Nasdaq is a material event. It will likely have an adverse effect on the liquidity and marketability of Functional Brands Inc.’s shares. The stock may be forced to trade over-the-counter (“OTC”), which usually results in lower trading volumes and higher volatility.
- Ongoing Operations: Despite the delisting notice, the company continues to operate. Its portfolio includes the longstanding Kirkman® brand of nutritional supplements, the P2i™ by Kirkman® prenatal product, and the Tru2u.health telehealth platform. Functional Brands also operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon.
Forward-Looking Statements and Risks
The company warns investors that this press release contains forward-looking statements regarding its intention to appeal the Nasdaq determination, the likely outcome of any appeal, and its ability to regain compliance with Nasdaq requirements. These statements are subject to numerous risks and uncertainties, including but not limited to the outcome of the appeal, the company’s ability to present a credible plan to regain compliance, and broader market and economic conditions. There is no obligation to update these statements except as required by law.
Investor Relations Contact
Investors with questions are encouraged to reach out to [email protected] or visit the company’s websites at www.functionalbrandsinc.com, www.kirkmangroup.com, and www.Tru2u.health.
Disclaimer: This article is intended for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a professional advisor before making investment decisions. All forward-looking statements are subject to risks and uncertainties and actual outcomes may differ materially.
